Connie Tat

Connie Tat is a Senior Medical Science Director in Oncology at Genentech, with extensive experience in leading clinical development and strategic initiatives in the oncology sector. At Genentech, Connie has been instrumental in overseeing a Phase 3 trial in bladder cancer, chaired study reviews for over 30 clinical studies, and collaborated on a personalized mRNA cancer vaccine project with BioNTech. Prior roles include serving as a Senior Medical Scientist at Amgen, where Connie led pipeline strategies, and as Senior Manager of Competitive Intelligence at Exelixis, focusing on the cabozantinib franchise. Additional experience includes market research consulting at Kantar Health and launching an equity research franchise at SunTrust Robinson Humphrey. Academic credentials include a Bachelor of Arts in Molecular and Cellular Biology from the University of California, Berkeley, and a Ph.D. in Immunology from UC Irvine.